GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » Price-to-Owner-Earnings

SC Ropharma (BSE:RPH) Price-to-Owner-Earnings : (As of May. 08, 2024)


View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma Price-to-Owner-Earnings?

As of today (2024-05-08), SC Ropharma's share price is lei0.19. SC Ropharma does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for SC Ropharma's Price-to-Owner-Earnings or its related term are showing as below:

BSE:RPH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.7   Med: 116.67   Max: 216
Current: 190

During the past 13 years, the highest Price-to-Owner-Earnings of SC Ropharma was 216.00. The lowest was 2.70. And the median was 116.67.


BSE:RPH's Price-to-Owner-Earnings is ranked worse than
96.62% of 266 companies
in the Healthcare Providers & Services industry
Industry Median: 20.595 vs BSE:RPH: 190.00

As of today (2024-05-08), SC Ropharma's share price is lei0.19. SC Ropharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was lei0.01. Therefore, SC Ropharma's PE Ratio for today is 21.11.

As of today (2024-05-08), SC Ropharma's share price is lei0.19. SC Ropharma's EPS without NRI for the trailing twelve months (TTM) ended in was lei0.00. Therefore, SC Ropharma's PE Ratio without NRI for today is 63.33.

During the past 13 years, SC Ropharma's highest PE Ratio without NRI was 63.33. The lowest was 8.57. And the median was 15.91.


SC Ropharma Price-to-Owner-Earnings Historical Data

The historical data trend for SC Ropharma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma Price-to-Owner-Earnings Chart

SC Ropharma Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 116.67 - - 208.00

SC Ropharma Semi-Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 208.00 - -

Competitive Comparison of SC Ropharma's Price-to-Owner-Earnings

For the Pharmaceutical Retailers subindustry, SC Ropharma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SC Ropharma's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where SC Ropharma's Price-to-Owner-Earnings falls into.



SC Ropharma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

SC Ropharma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.19/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SC Ropharma  (BSE:RPH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


SC Ropharma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of SC Ropharma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


SC Ropharma (BSE:RPH) Business Description

Traded in Other Exchanges
N/A
Address
Str. Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma (BSE:RPH) Headlines

No Headlines